CXCL10 and acute respiratory distress syndrome: Neutralization of CXCL10 ameliorates the severity of ARDS by inhibiting inflammatory cells recruitment into the lung, decreasing the production of inflammatory mediators, and consequently reducing pulmonary edema [56].